Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

About the Cover

November 1, 2019; Volume 60,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Aalbersberg, Else A.

    1. You have access
      Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma
      Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard and Marcel P.M. Stokkel
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1545-1552; DOI: https://doi.org/10.2967/jnumed.119.228312
  2. Abiodun-ojo, Olayinka A.

    1. You have access
      18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
      Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  3. Akerstrom, Bo

    1. You have access
      Recombinant α1-Microglobulin Is a Potential Kidney Protector in 177Lu-Octreotate Treatment of Neuroendocrine Tumors
      Charlotte K. Andersson, Emman Shubbar, Emil Schüler, Bo Åkerström, Magnus Gram and Eva B. Forssell-Aronsson
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1600-1604; DOI: https://doi.org/10.2967/jnumed.118.225243
  4. Akin-akintayo, Oladunni O.

    1. You have access
      18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
      Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  5. Akintayo, Akinyemi A.

    1. You have access
      18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
      Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  6. Alemozaffar, Mehrdad

    1. You have access
      18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
      Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  7. Aloj, Luigi

    1. You have access
      18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
      Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio and Secondo Lastoria
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1560-1568; DOI: https://doi.org/10.2967/jnumed.118.222604
  8. Aluicio-sarduy, Eduardo

    1. You have access
      Preclinical Characterization of 86/90Y-NM600 in a Variety of Murine and Human Cancer Tumor Models
      Joseph J. Grudzinski, Reinier Hernandez, Ian Marsh, Ravi B. Patel, Eduardo Aluicio-Sarduy, Jon Engle, Zachary Morris, Bryan Bednarz and Jamey Weichert
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1622-1628; DOI: https://doi.org/10.2967/jnumed.118.224808
  9. Andersson, Charlotte K.

    1. You have access
      Recombinant α1-Microglobulin Is a Potential Kidney Protector in 177Lu-Octreotate Treatment of Neuroendocrine Tumors
      Charlotte K. Andersson, Emman Shubbar, Emil Schüler, Bo Åkerström, Magnus Gram and Eva B. Forssell-Aronsson
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1600-1604; DOI: https://doi.org/10.2967/jnumed.118.225243
  10. Avallone, Antonio

    1. You have access
      18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
      Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio and Secondo Lastoria
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1560-1568; DOI: https://doi.org/10.2967/jnumed.118.222604
« Previous (Pages : 1 2 3 4 5 6 ... 20) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (11)
Journal of Nuclear Medicine
Vol. 60, Issue 11
November 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
  • Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice
  • Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
  • Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Questioning Standard Clinical Practice Requires Indisputable Scientific Data
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire